86123-51-5

Basic information

• Product Name: N-Cyan-4-phenyl-1-piperazinthiocarbimidsaeure-methylester
• CAS NO: 86123-51-5
• Molecular Weight: 260.363
• Mol File: 86123-51-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-Cyan-4-phenyl-1-piperazinthiocarbimidsaeure-methylester(CAS DataBase Reference)
• NIST Chemistry Reference: N-Cyan-4-phenyl-1-piperazinthiocarbimidsaeure-methylester(86123-51-5)
• EPA Substance Registry System: N-Cyan-4-phenyl-1-piperazinthiocarbimidsaeure-methylester(86123-51-5)

Safety Data

• Hazardous Substances Data: 86123-51-5(Hazardous Substances Data)

Upstream product

• 92-54-6 4-phenyl-1-piperazine 
• 10191-60-3 dimethyl N-cyanodithioiminocarbonate 

Downstream Products

• 99967-85-8 4-Amino-2-(4-phenylpiperazino)-5-thiazolcarboxamid 
• 86123-84-4 N-Phenyl-N'-<5-(4-phenyl-1-piperazinyl)-1-methyl-1H-1,2,4-triazol-3-yl>thioharnstoff 
• 86123-59-3 4-Amino-2-(4-phenyl-1-piperazinyl)-5-thiazolcarbonsaeure-methylester 
• 118630-19-6 5-(4-Phenyl-piperazin-1-yl)-4H-[1,2,4]triazol-3-ylamine 
• 86123-63-9 1-Methyl-3-(4-phenyl-1-piperazinyl)-1H-1,2,4-triazol-5-amin 
• 86123-64-0 1-Methyl-5-(4-phenyl-1-piperazinyl)-1H-1,2,4-triazol-3-amin 
• 99967-89-2 2-(4-Phenylpiperazino)thiazolo<4,5-d>pyrimidin-7(6H)-on 

Relevant articles and documents

N-sulfonylcarboximidamide apoptosis promoters

Compounds having the formula are apoptosis promoters. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

5-(1-Piperazinyl)-1H-1,2,4-triazol-3-amines as antihypertensive agents

A series of 5-(1-piperazinyl)-1H-1,2,4-triazol-3-amines was synthesized and screened for antihypertensive and diuretic activity in spontaneously hypertensive rats (SHR). One compound, 5-[4-[(3-chlorophenyl)methyl]-1-piperazinyl]-1H-1,2,4-triazol-3-amine (8), was selected to define the mechanism of its antihypertensive activity. Studies in SHR suggest ganglionic blocking activity. Short-lived antihypertensive activity was observed in conscious renal hypertensive dogs.